clock menu more-arrow no yes

Filed under:

Russia just approved the first COVID-19 prescription drug for sale in pharmacies

Russia has approved a new treatment for outpatients who have mild to moderate COVID-19 symptoms

In this handout photo taken on Thursday, Aug. 6, 2020, and provided by Russian Direct Investment Fund, a new vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia.
In this handout photo taken on Thursday, Aug. 6, 2020, and provided by Russian Direct Investment Fund, a new vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia.
Associated Press

Russia has now released a prescription drug to help outpatients ho have mild to moderate coronavirus symptoms, Reuters reports.

What’s going on?

Russia approved its new R-Pharm’s Coronavir treatment for sale in drug stores.

  • The drug could be rolled out to pharmacies within the country over the next week or so, according to Reuters.
  • Coronavir and Avifavir are two prescription drugs for COVID-19 that are based off of Favipiravir, which was made in Japan to treat viruses, according to Reuters.

Don’t forget ...

Coronavir received approval after a small clinical trial with 168 patients, Reuters reporters.

Russia continues to seek vaccine success

Russia’s potential coronavirus vaccine continues to go trough multiple trials to see its effectiveness, which I wrote about for Deseret.com.

A peer-reviewed study in The Lancet found Russia’s vaccine has had no major side effects.

  • The trials “did not find any serious adverse effects among participants, and confirmed that the vaccine candidates elicit an antibody response,” the study’s authors wrote.
  • “Large, long-term trials including a placebo comparison, and further monitoring are needed to establish the long-term safety and effectiveness of the vaccine for preventing COVID-19 infection.”